NICE Acts to Make Tagrisso Available to Patients in UK with Agressive Lung Cancer
Lung Cancer, News
The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending Tagrisso (osimertinib) be made available within the National Health Service (NHS) in England and Wales to treat a particularly aggressive form ... Read more